FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297989059> ?p ?o ?g. }

• W4297989059 abstract "Crimean-Congo hemorrhagic fever (CCHF) is a viral hemorrhagic fever, which is common in Turkey and globally. The pathogenesis of coagulation disorders, which is seen in viral hemorrhagic fevers remains to be elucidated. Thrombin-activatable fibrinolysis inhibitor (TAFI) has a key role in this process In this study, we aimed to evaluate whether TAFI levels contributed to bleeding and whether it is related to prognosis in CCHF patients. Eighty-four patients older than 15 years of age, who were admitted to our hospital who had positive immunoglobulin M (enzyme-linked immunosorbent assay [ELISA]) and/or polymerase chain reaction test results for CCHF between 2009 and 2010, were included in the study. The control group included 30 healthy adults. The plasma TAFI levels were compared between patients and controls, and also between patients with bleeding and no bleeding, and between patients with mild-moderate and severe disease. The mean TAFI levels were lower in patients (mean: 87.82 ng/ml, median: 61.69 ng/ml (interquartile range [IQR] 30.49-537.95) than controls (mean: 313.5 ng/ml with a median: 338.5 ng/ml (IQR 182-418). However, median TAFI levels were significantly higher in patients with bleeding compared to those without bleeding (78.99 and 50.28 ng/ml, respectively; p = 0.032). Median IQR TAFI levels were similar between patients with mild-moderate and severe disease (64.72 (41.37-113.85), and, 58.66 (42.44-118.93) ng/ml, respectively; p = 0.09) and survivors and nonsurvivors (86.14 ± 77.98 and 103.48 ± 69.92, respectively; p = 0.3). Although TAFI levels were lower in the patients with CCHF compared to healthy controls, it does not seem to be a major player in the prognosis." @default.
• W4297989059 created "2022-10-01" @default.
• W4297989059 creator A5005672818 @default.
• W4297989059 creator A5045151710 @default.
• W4297989059 creator A5049076570 @default.
• W4297989059 creator A5063976836 @default.
• W4297989059 creator A5076943240 @default.
• W4297989059 date "2022-10-08" @default.
• W4297989059 modified "2023-10-14" @default.
• W4297989059 title "Serum thrombin‐activatable fibrinolysis inhibitor levels and its relation with <i>pathogenesis and bleeding and prognosis</i> in patients with Crimean Congo hemorrhagic fever" @default.
• W4297989059 cites W1514226843 @default.
• W4297989059 cites W1967464330 @default.
• W4297989059 cites W1977497608 @default.
• W4297989059 cites W2015943267 @default.
• W4297989059 cites W2046768393 @default.
• W4297989059 cites W2053352964 @default.
• W4297989059 cites W2053367545 @default.
• W4297989059 cites W2066134050 @default.
• W4297989059 cites W2085818819 @default.
• W4297989059 cites W2102656137 @default.
• W4297989059 cites W2113231199 @default.
• W4297989059 cites W2132581196 @default.
• W4297989059 cites W2136048242 @default.
• W4297989059 cites W2143184176 @default.
• W4297989059 cites W2143232661 @default.
• W4297989059 cites W2154802237 @default.
• W4297989059 cites W2171812546 @default.
• W4297989059 cites W2211883562 @default.
• W4297989059 cites W2334210452 @default.
• W4297989059 cites W2776590467 @default.
• W4297989059 cites W2954623740 @default.
• W4297989059 cites W2981372467 @default.
• W4297989059 cites W4243436331 @default.
• W4297989059 doi "https://doi.org/10.1002/jmv.28182" @default.
• W4297989059 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36175009" @default.
• W4297989059 hasPublicationYear "2022" @default.
• W4297989059 type Work @default.
• W4297989059 citedByCount "0" @default.
• W4297989059 crossrefType "journal-article" @default.
• W4297989059 hasAuthorship W4297989059A5005672818 @default.
• W4297989059 hasAuthorship W4297989059A5045151710 @default.
• W4297989059 hasAuthorship W4297989059A5049076570 @default.
• W4297989059 hasAuthorship W4297989059A5063976836 @default.
• W4297989059 hasAuthorship W4297989059A5076943240 @default.
• W4297989059 hasConcept C119060515 @default.
• W4297989059 hasConcept C126322002 @default.
• W4297989059 hasConcept C203014093 @default.
• W4297989059 hasConcept C2776825266 @default.
• W4297989059 hasConcept C2778748088 @default.
• W4297989059 hasConcept C2779134260 @default.
• W4297989059 hasConcept C2780942790 @default.
• W4297989059 hasConcept C3019213423 @default.
• W4297989059 hasConcept C71924100 @default.
• W4297989059 hasConcept C90924648 @default.
• W4297989059 hasConceptScore W4297989059C119060515 @default.
• W4297989059 hasConceptScore W4297989059C126322002 @default.
• W4297989059 hasConceptScore W4297989059C203014093 @default.
• W4297989059 hasConceptScore W4297989059C2776825266 @default.
• W4297989059 hasConceptScore W4297989059C2778748088 @default.
• W4297989059 hasConceptScore W4297989059C2779134260 @default.
• W4297989059 hasConceptScore W4297989059C2780942790 @default.
• W4297989059 hasConceptScore W4297989059C3019213423 @default.
• W4297989059 hasConceptScore W4297989059C71924100 @default.
• W4297989059 hasConceptScore W4297989059C90924648 @default.
• W4297989059 hasIssue "1" @default.
• W4297989059 hasLocation W42979890591 @default.
• W4297989059 hasLocation W42979890592 @default.
• W4297989059 hasOpenAccess W4297989059 @default.
• W4297989059 hasPrimaryLocation W42979890591 @default.
• W4297989059 hasRelatedWork W1734535369 @default.
• W4297989059 hasRelatedWork W2034981248 @default.
• W4297989059 hasRelatedWork W2061253854 @default.
• W4297989059 hasRelatedWork W2135221496 @default.
• W4297989059 hasRelatedWork W2512153208 @default.
• W4297989059 hasRelatedWork W2754890083 @default.
• W4297989059 hasRelatedWork W2971392718 @default.
• W4297989059 hasRelatedWork W3162511055 @default.
• W4297989059 hasRelatedWork W4297989059 @default.
• W4297989059 hasRelatedWork W2739024173 @default.
• W4297989059 hasVolume "95" @default.
• W4297989059 isParatext "false" @default.
• W4297989059 isRetracted "false" @default.
• W4297989059 workType "article" @default.